Trichogin GA IV -OH

General Information


DRACP ID  DRACP03571

Peptide Name   Trichogin GA IV -OH

Sequence  XGLXGGLXGIL

Sequence Length  11

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  C8

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C32H52N8O6

Absent amino acids  ACDEFHKMNPQRSTVWY

Common amino acids  G

Mass  115338

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  4

Net charge  0

Boman Index  2344

Hydrophobicity  130

Aliphatic Index  141.82

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25306964

Title  The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity

Doi Not available

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  7739

DRACP is developed by Dr.Zheng's team.